US Stocks
United Therapeutics Corp
United Therapeutics Corp

United Therapeutics Corp (UTHR)


  • $







Key Stats

Today Low/High$198.05 / $200.54
52 Week Low/High$153.92 / $218.38
P/E ratio20.19
Market Cap$9.24B

Company Details

United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens - having a positive impact on patients, the environment and society - will sustain our success in the long term. Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
OrganisationUnited Therapeutics Corp
HeadquatersSilver Spring, Maryland, United States
IndustryHealth Technology
CEOMartine Rothblatt

Discover more

Frequently Asked Questions

What is United Therapeutics Corp (UTHR) share price today?

Can Indians buy United Therapeutics Corp (UTHR) shares?

How can I buy United Therapeutics Corp (UTHR) shares from India?

Can Fractional shares of United Therapeutics Corp (UTHR) be purchased?

What are the documents required to start investing in United Therapeutics Corp (UTHR) stocks?